Wuhan HealthCare Biotechnology Co., Ltd. was co-founded in February 2013 by an entrepreneurial team with a rich domestic and foreign experience in the Medical Devices industry. The company is positioned to provide clinical diagnosis for major diseases and guidance for clinical drug molecular diagnostic products, clinical molecular diagnostics holistic services provider for level two and above clinical hospitals and third-party clinical independent testing institutions. Wuhan HealthCare Biotechnology Co., Ltd. product and services are mainly used in areas such as Cardiovascular and Cerebrovascular diseases, Tumor, Cancer and other major diseases. The company five to six years plan is to become the industry’s technology, marketing, service and leading brand key player.
With the business philosophy of "Technological Innovation and Business Model Innovation", the company makes full use of the government platforms such as Optics Valley Biolake and Wuhan Biotechnology Research Institute and extensively cooperates with clinical hospitals, internationally renowned upstream suppliers and research institutions in the field of biology from home and abroad; Adoption of an integrated R&D program to enhance R&D efficiency, product technology and product customer satisfaction, high-speed enterprise development strategy and gradually develop core competitive advantages such as advanced technology, light assets, high efficiency, cost reduction as its contribution to the China's health care industry.